FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
NEW YORK, Oct. 03, 2016 -- EMBER THERAPEUTICS (OTCQB:EMBT), today announced that Olympic Gold Medalist Ryan Lochte has signed an endorsement agreement with the company. Lochte, one of the stars of Team USA, has won 12 Olympic medals, including six gold medals, three silver medals and three bronze medals making him one of the most decorated swimmers in Olympic history.
The University of Florida graduate swam his way to victory countless times as a member of the Florida Gators swimming team, and was named NCAA Swimmer of the Year twice. He also became a seven-time NCAA champion, a seven-time SEC champion and a 24-time All-American. Lochte, who was born in Rochester New York, is currently a contestant on the Emmy nominated Dancing with the Stars.
“Ember Therapeutics’ Migralex is one of the top names in over the counter pain and headache relief and I’m thrilled to be in partnership with them,” said Lochte.
“Ryan Lochte has had an outstanding athletic career,” said Joseph Hernandez, Executive Chairman of Ember Therapeutics, Inc., “We are honored to have him be our spokesperson for Migralex, the only over the counter pain medicine containing Magnesium, which is easier on the stomach and further enhances the drug’s ability to deal with difficult headaches and most types of pain.”
As a result of over 25 years of research, a world renowned neurologist has developed and patented a breakthrough headache medicine that has been clinically proven to be highly effective in relieving most types of pain, including arthritis pain, tension headaches, sinus headaches, stress headaches, menstrual headaches, and various other pains.
Migralex™ is a patented product and is the strongest combination pain medicine available without a prescription. Its special rapid release formula gives fast acting relief, and is gentle on the stomach. Migralex™ reduces side effects common with other OTC pain relievers. It contains no caffeine, sodium or preservatives, and contains magnesium as a buffering agent.
Migralex™ is currently available at CVS, local pharmacies, online at Amazon.com and the product website www.migralex.com. To learn more about Migralex™ please access www.migralex.com.
About Ember Therapeutics, Inc.
Ember Therapeutics, Inc. is a diversified pharmaceutical company commercializing and developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has several commercial stage products and two late stage Phase 3 ready assets. For more information, please visit www.embertx.com.
Contact Information: Betty Rose (investors) (646) 406-6243 [email protected]
